Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Regulatory News

Date Source Headline
22nd Jul 2024 7:00 am RNS Appointment of Nominated Adviser and Sole Broker
4th Jul 2024 2:22 pm RNS Launch of new Company Long Term Incentive Plan
27th Jun 2024 7:00 am RNS Appointment of Non-Executive Director
10th Jun 2024 7:00 am RNS Progression of patient cohorts in PROTECT Trial
3rd Jun 2024 7:00 am RNS Successful meetings with Paul Ehrlich Institut
31st May 2024 7:00 am RNS Allergy Therapeutics presents findings at EAACI
7th May 2024 7:00 am RNS Further detail from G306 Phase III field trial
3rd Apr 2024 7:00 am RNS Director Resignation
27th Mar 2024 7:00 am RNS Update on funding
27th Mar 2024 7:00 am RNS Interim Results for six months ended 31 Dec 2023
12th Mar 2024 8:59 am RNS VLP Peanut PROTECT Trial Update
12th Mar 2024 7:00 am RNS VLP Peanut PROTECT Trial Update
11th Mar 2024 7:00 am RNS Appointment of Shaun Furlong to Board of Directors
8th Mar 2024 1:49 pm RNS Result of AGM
14th Feb 2024 7:00 am RNS Half-Year Trading Update 2024
9th Feb 2024 3:07 pm RNS Notice of 2023 Annual General Meeting
30th Jan 2024 7:30 am RNS Restoration - Allergy Therapeutics plc
30th Jan 2024 7:00 am RNS Publication of Annual Report and Accounts 2023
4th Jan 2024 12:29 pm RNS Total Voting Rights
2nd Jan 2024 7:30 am RNS Suspension - Allergy Therapeutics plc
27th Dec 2023 12:01 pm RNS Amendment to existing Facility Agreement
15th Dec 2023 12:48 pm RNS Annual Report and Accounts Delayed
13th Dec 2023 4:54 pm RNS PDMR dealing and Total Voting Rights
13th Dec 2023 7:00 am RNS G306 Phase III trial meets key endpoints
11th Dec 2023 7:00 am RNS Update on funding
1st Dec 2023 7:00 am RNS Total Voting Rights
28th Nov 2023 3:03 pm RNS Holding(s) in Company
14th Nov 2023 7:00 am RNS G306 Grass Phase III trial meets primary endpoint
10th Nov 2023 2:39 pm RNS Form 8.5 (EPT/RI)
10th Nov 2023 1:22 pm RNS Director/PCA Dealing
10th Nov 2023 1:11 pm RNS Holding(s) in Company
10th Nov 2023 7:00 am RNS Offer Closure
9th Nov 2023 10:48 am RNS Exercise of Options and Total Voting Rights
9th Nov 2023 9:24 am RNS Form 8.5 (EPT/RI)
9th Nov 2023 9:15 am RNS Form 8.5 (EPT/NON-RI)
8th Nov 2023 10:45 am RNS Form 8.5 (EPT/RI)
7th Nov 2023 11:10 am RNS Form 8.5 (EPT/RI)
6th Nov 2023 9:33 am RNS Form 8.5 (EPT/RI)
6th Nov 2023 7:00 am RNS Update on funding
3rd Nov 2023 9:31 am RNS Form 8.5 (EPT/RI)
FTSE 100 Latest
Value10,090.77
Change-104.58